Tagged with R

Bulgaria Jivko Ivanov, chairman of the Healthcare Commission of the German-Bulgarian Chamber of Industry and Commerce, explains the strong commercial ties linking the two countries, the opportunities Bulgaria can offer to foreign companies, especially from Germany, and how the Chamber can help create strong business collaborations. On the 7th of August…

Austria Ulrich Schlick, deputy managing director of the German Chamber of Commerce in Austria, discusses the Chamber’s role in facilitating business opportunities for German companies in Austria and vice versa. He also provides an overview of the cultural ties and differences between the countries and the potential of Austria for German…

Switzerland Saad Harti, president of Legacy Healthcare, discusses the company’s origins, their unique focus on side-effect free botanical drugs for chronic conditions, and the importance of stakeholder education in this exciting but still immature field.   Most of our current emphasis is on alleviating side effects of cancer treatments, also called…

Austria Bernd Grabner, board member of Jacoby GM pharma, a leading Austrian wholesaler, provides an in-depth look into the historical merger of family owned Jacoby, GM pharma and Kӧgl Pharma as well as the moves being made to bolster a vertically integrated business model. Furthermore, he gives an overview of the…

Austria Barbara Fritsche-Surchat, general manager of Servier Austria, a leading innovative French company looking to bolster its global oncology presence, provides an in-depth analysis of the balancing act between pricing and market access in the Austrian healthcare system as well as how the company’s global oncology vision has influenced Austrian operations.…

Bulgaria Dr. Atanas Atanasov, country manager at Angelini Bulgaria, explains the affiliate’s growth to become a top ten player in the Bulgarian industry and highlights the leadership position of its portfolio in each category based on a long-term promotion strategy and value-based quality. Angelini started its internationalisation process ten years ago,…

Austria Martin Spatz, country manager of QuintilesIMS Austria, the global leader in healthcare market research, discusses the diverse range of services they provide to the two separate entities of the of Austrian healthcare system: the retail and hospital sectors. Furthermore, he provides an in-depth look at the positive impact of accurate…

Brazil In an exclusive interview, Minister of Health of Brazil Ricardo Barros provides insights into his main achievements since being appointed in May 2016 and his key priorities to further improve the management and delivery of Brazil’s public health system, while highlighting his expectations for pharmaceutical companies implanted in the country.…

Austria Rudolf Wessely, CEO and founder of Gynial, the Austrian leader in oral contraceptives, elaborates on the company’s incredibly fast market penetration since 2007 and explains his expertise in the contraceptive field. Furthermore, he discusses the importance of open communication with gynaecologists and Gynial’s unique product philosophy as well as the…

Canada Dr. Jeremy B. Desai, CEO & President of Apotex, the Canadian international generics powerhouse, discusses his mandate in 2014 to take the company global, the challenges and opportunities of increasing convergence between the generics, branded and biosimilars sectors globally, and the main growth engines for Apotex looking forward. Jeremy, you…

Austria Bernhard Wittmann, managing director of Sigmapharm and MoNo, discusses the company’s product portfolio and the diverse tailored services for their partners. Furthermore, he provides an in-depth look into MoNo’s new 20 million EUR (24 million USD) CMO production plant that will be completed in 2019. The ten-fold increase in capacity…

Tunisia Christophe Sauer, president at Sephire, the association of innovative pharmaceutical companies in Tunisia, talks us through the challenges that innovative MNCs are facing in the country, especially in terms of pricing, but also highlights the important efforts that have been made in public-private dialogues. Mr. Sauer, could you please introduce…